key: cord-0965773-1uodle5h
authors: Lim, Cynthia Ciwei; Choo, Jason; Tan, Chieh Suai
title: COVID-19 Vaccination in Immunoglobulin A Nephropathy
date: 2021-07-14
journal: Am J Kidney Dis
DOI: 10.1053/j.ajkd.2021.07.001
sha: 27018e5b8220a13d64672a250b539d22daf52b9b
doc_id: 965773
cord_uid: 1uodle5h

nan

To the Editor:

The timely editorial from Bomback et al on de novo and relapsing glomerular diseases after COVID-19 vaccination noted that immunoglobulin A nephropathy (IgAN) was one of the most frequently reported glomerulonephritides in this context 1 . However, the absolute incidence was low, with 10 reports of de novo or relapsed IgAN, including 1 from our institution 2 . Vaccine safety data in IgAN are lacking in part because immunosuppressed patients, including those with glomerular diseases, were generally excluded 3 

De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?

Is COVID-19 vaccination unmasking glomerulonephritis? Kidney Int

Systematic Review of Safety and Efficacy of COVID-19 Vaccines in Patients With Kidney Disease

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study